Rebecca M. Henderson

Rebecca M. Henderson has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Idexx Laboratories INC /de and Amgen Inc. Over a trading history stretching from 30 January 2006 to 23 February 2021, the count stands at 74 filings.

In open-market terms, that means 1 purchase worth €65k on one side and 25 sales worth €18.2M on the other. On balance, insiders were net sellers of €18.2M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 29 share grants and 19 option exercises. 2021 to date brings no purchases and 1 sale.

The newest entry dates from 25 February 2021: an option exercise of €401k, in Idexx Laboratories INC /de. The last insider purchase was made public on 20 February 2007, 7,201 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.